122 related articles for article (PubMed ID: 18328068)
21. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization.
Ono T; Imai K; Kohno H; Uchida M; Takemoto Y; Dhar DK; Nagasue N
Dig Dis Sci; 1998 Oct; 43(10):2201-10. PubMed ID: 9790455
[TBL] [Abstract][Full Text] [Related]
22. The influence of severity of bile flow reduction, cycloheximide, and methyl isobutyl ketone pretreatment on the kinetics of taurolithocholic acid disposition in the rat.
Dahlström-King L; du Souich P; Couture J; Plaa GL
Toxicol Appl Pharmacol; 1990 Jun; 104(2):312-21. PubMed ID: 2363182
[TBL] [Abstract][Full Text] [Related]
23. Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo.
Mottino A; Tuchweber B; Plaa GL; Yousef IM
Toxicol Lett; 2000 Jul; 116(1-2):69-77. PubMed ID: 10906424
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO-3 exchanger in the rat.
Alvaro D; Gigliozzi A; Piat C; Carli L; Fraioli F; Romeo R; Francia C; Attili AF; Capocaccia L
J Hepatol; 1997 Jan; 26(1):146-57. PubMed ID: 9148006
[TBL] [Abstract][Full Text] [Related]
25. Effect of chronic administration of taurolithocholate on bile formation and liver ultrastructure in the rat.
Gratton F; Weber AM; Tuchweber B; Morazain R; Roy CC; Yousef IM
Liver; 1987 Jun; 7(3):130-7. PubMed ID: 3613882
[TBL] [Abstract][Full Text] [Related]
26. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
27. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-activated protein kinases are involved in hepatocanalicular dysfunction and cholestasis induced by oxidative stress.
Toledo FD; Basiglio CL; Barosso IR; Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Roma MG
Arch Toxicol; 2017 Jun; 91(6):2391-2403. PubMed ID: 27913845
[TBL] [Abstract][Full Text] [Related]
29. Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver.
Delle Monache MD; Gigliozzi A; Benedetti A; Marucci L; Bini A; Francia C; Papa E; Di Cosimo E; Fraioli F; Jezequel AM; Alvaro D
Dig Dis Sci; 1999 Nov; 44(11):2196-204. PubMed ID: 10573362
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
31. Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver.
Utili R; Adinolfi LE; Gaeta GB; Tripodi MF; Alvaro D
Digestion; 1987; 36(2):74-80. PubMed ID: 3552808
[TBL] [Abstract][Full Text] [Related]
32. Effect of cadmium on bromosulfophthalein kinetics in the isolated perfused rat liver system.
Soto A; Foy BD; Frazier JM
Toxicol Sci; 2002 Oct; 69(2):460-9. PubMed ID: 12377995
[TBL] [Abstract][Full Text] [Related]
33. Influence of agents affecting monooxygenase activity on taurolithocholic acid-induced cholestasis.
Dahlström-King L; Couture J; Plaa GL
Toxicol Lett; 1992 Dec; 63(3):243-52. PubMed ID: 1283232
[TBL] [Abstract][Full Text] [Related]
34. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats.
Kurz AK; Graf D; Schmitt M; Vom Dahl S; Häussinger D
Gastroenterology; 2001 Aug; 121(2):407-19. PubMed ID: 11487550
[TBL] [Abstract][Full Text] [Related]
35. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes.
Beuers U; Nathanson MH; Boyer JL
Gastroenterology; 1993 Feb; 104(2):604-12. PubMed ID: 8425704
[TBL] [Abstract][Full Text] [Related]
36. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
Wang L; Piguet AC; Schmidt K; Tordjmann T; Dufour JF
Hepatology; 2005 Jun; 41(6):1241-51. PubMed ID: 15861431
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes.
Bouscarel B; Fromm H; Nussbaum R
Am J Physiol; 1993 Feb; 264(2 Pt 1):G243-51. PubMed ID: 8447407
[TBL] [Abstract][Full Text] [Related]
38. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
Schoemaker MH; Gommans WM; Conde de la Rosa L; Homan M; Klok P; Trautwein C; van Goor H; Poelstra K; Haisma HJ; Jansen PL; Moshage H
J Hepatol; 2003 Aug; 39(2):153-61. PubMed ID: 12873810
[TBL] [Abstract][Full Text] [Related]
39. Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes.
Beuers U; Probst I; Soroka C; Boyer JL; Kullak-Ublick GA; Paumgartner G
Hepatology; 1999 Feb; 29(2):477-82. PubMed ID: 9918925
[TBL] [Abstract][Full Text] [Related]
40. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.
Benz C; Angermüller S; Klöters-Plachky P; Sauer P; Stremmel W; Stiehl A
Eur J Clin Invest; 1998 Jul; 28(7):577-83. PubMed ID: 9726039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
